Valneva SE American Depositary Shares (VALN) Stock Price, Quote & AI Analysis

Live VALN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Valneva SE American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Valneva SE American Depositary Shares (VALN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

V
VALN
Valneva SE American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
10.600000
High
10.600000
Low
10.310000
Volume
3,394
VWAP
-
Market Cap
$896,565,985.68
52W Range
$5.43 - $12.25
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Valneva SE American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Valneva SE American Depositary Shares Overview

Company information

Company Overview

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Company Details
Market Cap
$892.28M
Shares Outstanding
86,044,339
Weighted Shares Outstanding
86,876,549
CEO
Thomas Lingelbach
Employees
674
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Valneva SE American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...